David B. Kanne

4.6k total citations · 2 hit papers
30 papers, 3.4k citations indexed

About

David B. Kanne is a scholar working on Organic Chemistry, Immunology and Molecular Biology. According to data from OpenAlex, David B. Kanne has authored 30 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 9 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in David B. Kanne's work include interferon and immune responses (9 papers), Synthesis of Organic Compounds (5 papers) and Insect and Pesticide Research (4 papers). David B. Kanne is often cited by papers focused on interferon and immune responses (9 papers), Synthesis of Organic Compounds (5 papers) and Insect and Pesticide Research (4 papers). David B. Kanne collaborates with scholars based in United States and Germany. David B. Kanne's co-authors include Thomas W. Dubensky, Henry Rapoport, John E. Hearst, Kenneth Straub, Justin J. Leong, Kelsey E. Sivick, Sarah M. McWhirter, Edward E. Lemmens, Laura Hix Glickman and Ken Metchette and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Molecular Biology and Biochemistry.

In The Last Decade

David B. Kanne

30 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

2015 1.1k citations Leticia Corrales, Laura Hix Glickman et al. Cell Reports profile →
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

2015 581 citations Juan Fu, David B. Kanne et al. Science Translational Medicine profile →

Peers

Countries citing papers authored by David B. Kanne

Since Specialization

Citations

This map shows the geographic impact of David B. Kanne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Kanne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Kanne more than expected).

Fields of papers citing papers by David B. Kanne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Kanne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Kanne. The network helps show where David B. Kanne may publish in the future.

Co-authorship network of co-authors of David B. Kanne

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Kanne. A scholar is included among the top collaborators of David B. Kanne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Kanne. David B. Kanne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection 2018 ·Cell Reports ·Erik Van Dis, Kimberly M. Sogi, Chris S. Rae, Kelsey E. Sivick, Natalie H. Surh, Meredith L. Leong, David B. Kanne, Ken Metchette, Justin J. Leong, (unknown), Vivian Hsueh Hua Chen, Kartoosh Heydari, Nathalie Cadieux, Tom Evans, Sarah M. McWhirter, Thomas W. Dubensky, Daniel A. Portnoy, Sarah A. Stanley	91
2	A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice 2017 ·Cancer Immunology Research ·Jeremy B. Foote, Marleen Kok, James M. Leatherman, Todd D. Armstrong, (unknown), Laureen S. Ojalvo, David B. Kanne, Elizabeth M. Jaffee, Thomas W. Dubensky, Leisha A. Emens	117
3	Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors 2015 ·Cancer Research ·Jason R. Baird, David J. Friedman, Benjamin Cottam, Thomas W. Dubensky, David B. Kanne, Shelly Bambina, Keith S. Bahjat, Marka R. Crittenden, Michael J. Gough	201
4	Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity breakdown → 2015 ·Cell Reports ·Leticia Corrales, Laura Hix Glickman, Sarah M. McWhirter, David B. Kanne, Kelsey E. Sivick, George E. Katibah, Seng‐Ryong Woo, Edward E. Lemmens, (unknown), Justin J. Leong, Ken Metchette, Thomas W. Dubensky, Thomas F. Gajewski	1146
5	STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade breakdown → 2015 ·Science Translational Medicine ·Juan Fu, David B. Kanne, Meredith L. Leong, Laura Hix Glickman, Sarah M. McWhirter, Edward E. Lemmens, (unknown), Justin J. Leong, Peter Lauer, Weiqun Liu, Kelsey E. Sivick, Qi Zeng, Kevin C. Soares, Lei Zheng, Daniel A. Portnoy, Joshua J. Woodward, Drew M. Pardoll, Thomas W. Dubensky, Young Kim	581
6	Intratumoral injection of STING ligand promotes abscopal effect 2014 ·Journal for ImmunoTherapy of Cancer ·Jason R. Baird, Thomas W. Dubensky, David B. Kanne, David J. Friedman, Benjamin Cottam, Shelly Bambina, Keith S. Bahjat, Marka R. Crittenden, Michael J. Gough	1
7	Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cellsin vitrovia hyperthermia 2011 ·International Journal of Hyperthermia ·Jianping Zhang, Abiche H. Dewilde, Paul Chinn, Allan R. Foreman, Stephen Barry, David B. Kanne, Susan J. Braunhut	37
8	Nitroso-Imidacloprid Irreversibly Inhibits Rabbit Aldehyde Oxidase 2007 ·Chemical Research in Toxicology ·Ryan A. Dick, David B. Kanne, John E. Casida	14
9	6′-Methylpyrido[3,4-b]norhomotropane: synthesis and outstanding potency in relation to the α4β2 nicotinic receptor pharmacophore model 2005 ·Bioorganic & Medicinal Chemistry Letters ·David B. Kanne, Motohiro Tomizawa, Kathleen A. Durkin, John E. Casida	10
10	Identification of Aldehyde Oxidase as the Neonicotinoid Nitroreductase 2005 ·Chemical Research in Toxicology ·Ryan A. Dick, David B. Kanne, John E. Casida	61
11	Substrate Specificity of Rabbit Aldehyde Oxidase for Nitroguanidine and Nitromethylene Neonicotinoid Insecticides 2005 ·Chemical Research in Toxicology ·Ryan A. Dick, David B. Kanne, John E. Casida	37
12	Synthesis and biological characterization of pyridohomotropanes. Structure-activity relationships of conformationally restricted nicotinoids 1988 ·Journal of Medicinal Chemistry ·David B. Kanne, Leo G. Abood	49
13	Synthesis of the first highly potent bridged nicotinoid 9-Azabicyclo[4.2.1]nona[2,3-c]pyridine (pyrido[3,4-b]homotropane) 1986 ·Journal of the American Chemical Society ·David B. Kanne, (unknown), (unknown), Linda Mutter, Leo G. Abood	42
14	The reaction of the psoralens with deoxyribonucleic acid 1984 ·Quarterly Reviews of Biophysics ·John E. Hearst, Stephen T. Isaacs, David B. Kanne, Henry Rapoport, Kenneth Straub	136
15	ChemInform Abstract: 8‐METHOXYPSORALEN‐NUCLEIC ACID PHOTOREACTION. EFFECT OF METHYL SUBSTITUTION ON PYRONE VS. FURAN PHOTOADDITION 1984 ·Chemischer Informationsdienst ·David B. Kanne, Henry Rapoport, John E. Hearst	1
16	The psoralen-DNA photoreaction. Characterization of the monoaddition products from 8-methoxypsoralen and 4,5',8-trimethylpsoralen 1982 ·Biochemistry ·David B. Kanne, Kenneth Straub, Henry Rapoport, John E. Hearst	174
17	Structure of a psoralen-thymine monoadduct formed in photoreaction with DNA 1982 ·Journal of Molecular Biology ·(unknown), Bradford Graves, David B. Kanne, Henry Rapoport, John E. Hearst, Sung‐Hou Kim	77
18	Isolation and characterization of pyrimidine-psoralen photoadducts from DNA 1981 ·Journal of the American Chemical Society ·Kenneth Straub, David B. Kanne, John E. Hearst, Henry Rapoport	121
19	Preparation of cis- and trans-4-tert-butyl-1-phenylphosphorinane and a study of reaction stereochemistry of its derivatives 1977 ·The Journal of Organic Chemistry ·Kenneth L. Marsi, (unknown), (unknown), David B. Kanne	7
20	Kernresonanz‐Untersuchungen zu Fehlordnung und Platzwechsel der Ionen in den Kupfer(I)‐halogeniden 1970 ·Berichte der Bunsengesellschaft für physikalische Chemie ·(unknown), (unknown), David B. Kanne, (unknown), (unknown)	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact